Shopping Cart 0
Cart Subtotal
USD 0

MediPoint: HPV and EBV Tests-Global Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 6495

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 12990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 19485
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

MediPoint: HPV and EBV Tests-Global Analysis and Market Forecasts

Summary

HPV and EBV Tests include-

HPV Tests

EBV Tests

Growth in the HPV and EBV Tests market is driven by-

Improving screening and treatment of pre-cancer amongst women.

Diagnostic cytology improvements.

The global market for HPV and EBV Tests is led by-

Abbott

Bio-Rad

Hologic

Qiagen

Roche

Scope

Competitive assessment: Currently marketed HPV and EBV Tests and evolving competitive landscape

In-depth analysis of unmet needs and adoption trends of different HPV and EBV Tests

Insightful review of the key industry drivers, opportunities, restraints and challenges.

Annualized total HPV and EBV Tests market revenue by segment and market outlooks from 2017-2024.

Other key topics covered include strategic competitive assessment, identification of unmet needs, and market dynamics.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the HPV and EBV Tests market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HPV and EBV Tests market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific HPV and EBV Tests market from 2017-2024.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Table Of Content

Scope

Table of Contents

About the Authors

Table of Contents

List of Tables

List of Figures

Executive Summary

Overview

Market Dynamics

Key Players in the Market

Market Future Outlook

Introduction

Catalyst

Related Reports

Upcoming Related Reports

Market Outlook

Procedure Trends

Revenue Trends

Company Share Analysis

Market Access

Regulatory Issues

North America

Europe

APAC

South America

Middle East and Africa

Pricing Trends

North America

Europe

APAC

South America

Middle East and Africa

Opportunities, Unmet Needs and Barriers

Opportunities

Improving screening and treatment of pre-cancer among women

Sensitivity and Specificity

Diagnostic cytology improvements

Unmet Needs

Point of care testing

Lack of epidemiological studies for underdeveloped regions

Test and testing guidelines for Men

Barriers

Patient education

Reimbursement

Not approved for primary test

Market Insights

North America

Canada

Mexico

US

Europe

Denmark, Finland, Norway, and Sweden

Belgium, France, and Netherlands

Germany and Switzerland

UK and Ireland

Italy, Portugal, and Spain

Austria, Czech Republic, Hungary, and Poland

Greece, Russia, and Turkey

APAC

Australia and New Zealand

China and Taiwan

India

Japan

South Korea

South America

Brazil

Argentina and Chile

Middle East and Africa

Israel

South Africa

Egypt, Saudi Arabia, and United Arab Emirates

Competitive Assessment

Overview

Mergers and Acquisitions

Abbott

Overview

Portfolio Assessment

Competitive Positioning

Bio-Rad

Overview

Portfolio Assessment

Competitive Positioning

Hologic

Overview

Portfolio Assessment

Competitive Positioning

Qiagen

Overview

Portfolio Assessment

Competitive Positioning

Roche

Overview

Portfolio Assessment

Competitive Positioning

Other Players

Appendix

Bibliography

Abbreviations

Methodology

Overview

Coverage

Secondary Research

Forecasting Methodology

Primary Research Summary

About MediPoint

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Figure 1: HPV and EBV Global Sales, by Region, 2017 and 2024

Figure 2: HPV and EBV Sales for North America, by Country, 2017 and 2024

Figure 3: HPV and EBV Sales for Europe, by Country, 2017 and 2024

Figure 4: HPV and EBV Sales for APAC, by Country, 2017 and 2024

Figure 5: HPV and EBV Sales for South America, by Country, 2017 and 2024

Figure 6: HPV and EBV Sales for the Middle East and Africa, by Country, 2017 and 2024


List Of Table

List of Tables

Table 1: Key Metrics in the Global HPV and EBV Market

Table 2: North America HPV & EBV Tests Volume Forecast, 20-2024 (in thousands)

Table 3: Europe HPV & EBV Tests Volume Forecast, 20-2024 (in thousands)

Table 4: APAC HPV & EBV Tests Volume Forecast, 20-2024 (in thousands)

Table 5: South America HPV & EBV Tests Volume Forecast, 20-2024 (in thousands)

Table 6: Middle East and Africa HPV & EBV Tests Volume Forecast, 20-2024 (in thousands)

Table 7: North America HPV & EBV Tests Revenue Forecast (USDM), 20-2024

Table : Europe HPV & EBV Tests Revenue Forecast (USDM), 20-2024

Table : APAC HPV & EBV Tests Market Revenue Forecast (USDM), 20-2024

Table : South America HPV & EBV Tests Revenue Forecast (USDM), 20-2024

Table : Middle East and Africa HPV & EBV Tests Revenue Forecast (USDM), 20-2024

Table : North America HPV & EBV Tests Company Share Analysis, 2017

Table : Europe HPV & EBV Tests Company Share Analysis, 2017

Table : APAC HPV & EBV Tests Company Share Analysis, 2017

Table : South America HPV & EBV Tests Company Share Analysis, 2017

Table : Middle East and Africa HPV & EBV Tests Company Share Analysis, 2017

Table 17: North America HPV & EBV Average Selling Price Forecast (USD),20-2024

Table 1: Europe HPV & EBV Tests Average Selling Price Forecast (USD),20-2024

Table 1: APAC HPV & EBV Tests Average Selling Price Forecast (USD),20-2024

Table 20: South America HPV & EBV Tests Average Selling Price Forecast (USD),20-2024

Table 21: Middle East and Africa HPV & EBV Tests Average Selling Price Forecast (USD),20-2024

Table 22: Mergers and Acquisitions, HPV & EBV Tests

Table 23:Abbott-Key Marketed Products Assessment

Table 24: SWOT Analysis of Abbott in the HPV & EBV Tests, 2017

Table 25: Bio-Rad-Key Marketed Products Assessment

Table 26: SWOT Analysis of Bio-Rad in the HPV & EBV Tests, 2017

Table 27: Hologic-Key Marketed Products Assessment

Table 2: SWOT Analysis of Hologic in the HPV & EBV Tests, 2017

Table 2: Qiagen-Key Marketed Products Assessment

Table 30: SWOT Analysis of Qiagen in the HPV & EBV Tests, 2017

Table 31: Roche-Key Marketed Products Assessment 4

Table 32: SWOT Analysis of Roche in the HPV & EBV Tests, 2017

Table 33: Summary of Other Players in the HPV & EBV Tests Market, 2017

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Abbott, Bio-Rad, Hologic, Qiagen, Roche